A new study published today in JAMA Network Open projects that reductions in federal funding for syringe service programs (SSPs) could lead to substantial increases in mortality among people who inject drugs in the United States.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Abel brings demonstrated expertise to advance Delta Dental’s commitment to a People First culture DENVER, Nov. 17, 2022 /PRNewswire/ — Today, Delta Dental of Colorado (DDCO) announced the hiring of Stacy Abel as its chief […]
At ASHG, Seer showcased its Proteograph product suite which it claims delivers proteomic insights that complement and strengthen other forms of omics data. Through various sessions at the meeting, the company highlighted applications of the […]
TEMPE, Ariz., July 26, 2022 /PRNewswire/ — Today Solidarity HealthShare announced its support for new state laws and policies aimed at creating greater transparency in health care pricing: “Solidarity HealthShare strongly supports new legislation in […]
Copyright © 2026 Biotech Networks
